NCT03983291 FaReWell Depression - Facial Exercise Program to Treat Depression
| NCT ID | NCT03983291 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zentrum für Angst und Depressionsbehandlung Zürich |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2019-06-01 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2019-06-01 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates if a physiotherapeutic exercise program designed to relax facial muscles associated with the expression of negative emotions and to activate and strengthen facial muscles associated with the expression of positive emotions can reduce the symptoms of depression and improve wellbeing and quality of life in the affected patients.
Eligibility Criteria
Inclusion Criteria: * Mild to moderate unipolar depression * Stable treatment for at least 6 weeks Exclusion Criteria: * Organic mental disorders * Mental disorders due to psychoactive substance use * Schizophrenia and other psychotic disorders * Previous cosmetic procedures (botulinum toxin, fillers, lifting) * Facial palsy * Facial skin disorders
Contact & Investigator
Patricia Waldvogel, PhD
PRINCIPAL INVESTIGATOR
Zentrum für Angst und Depressionsbehandlung Zürich
Frequently Asked Questions
Who can join the NCT03983291 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03983291 currently recruiting?
Yes, NCT03983291 is actively recruiting participants. Contact the research team at PWaldvogel@zadz.ch for enrollment information.
Where is the NCT03983291 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT03983291 clinical trial?
NCT03983291 is sponsored by Zentrum für Angst und Depressionsbehandlung Zürich. The principal investigator is Patricia Waldvogel, PhD at Zentrum für Angst und Depressionsbehandlung Zürich. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.